Zain Khalpey: The Hidden Impact of Sex Hormones on Thrombosis and Heart Health
Zain Khalpey, Adjunct Assistant Professor of Surgery at Columbia University Irving Medical Center, shared a post on LinkedIn about a recent article by Leslie Skeith et al, adding:
“This visual outlines how estrogen, progesterone, and testosterone affect coagulation pathways, platelet activity, red blood cells, and vascular function.
These physiologic changes can alter clotting risk depending on dose, formulation, and patient specific factors.
Recent evidence highlights the importance of evaluating individual risk, including prior thrombosis, underlying conditions, and treatment indication when considering hormone therapy.
Clear understanding of these mechanisms supports safer clinical decision making across cardiology, internal medicine, and women’s health.
Follow Zain Khalpey for more on AI and Healthcare.”
Title: Sex Hormone Influences on Venous Thrombotic and Cardiovascular Risk
Authors: Leslie Skeith, Shannon M. Bates
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 17, 2026, 04:28Redefining Thromboprophylaxis in Multiple Myeloma: Early VTE Emerges as the Critical Therapeutic Challenge
-
Jul 16, 2026, 20:25Ilham Benzidia: Leaving ISTH 2026 With New Ideas and New Collaborations
-
Jul 16, 2026, 20:23Eman Hassan: A Fantastic Platelets and Megakaryocytes Session at ISTH 2026
-
Jul 16, 2026, 20:22Sankara Nelson Noah II: Investigating the Temporal Dynamics of Platelet – Leukocyte Interactions in Early Sepsis
-
Jul 16, 2026, 20:20Joseph Pierre Aboumsallem: Paris Certainly Delivered This Week, and Not Just Because of the Heat
-
Jul 16, 2026, 19:53Louise St. Germain Bannon: The End of Congress, the Beginning of New Collaborations
-
Jul 16, 2026, 19:18Steve Humphreys: Learning From the Leading Experts at ISTH 2026
-
Jul 16, 2026, 19:02Kellie Machlus: Where Science Meets Friendship at ISTH 2026
-
Jul 16, 2026, 18:51Aaron Paul Kithcart: When Clinical Research Comes Together at ISTH 2026